ArticleOncology letters2016

Hinokitiol inhibits vasculogenic mimicry activity of breast cancer stem/progenitor cells through proteasome-mediated degradation of epidermal growth factor receptor.

Dom-Gene Tu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.